Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy.

ACS nano

Yue Y, Li F, Li Y, Wang Y, Guo X, Cheng Z, Li N, Ma X, Nie G, Zhao X.
PMID: 34469109
ACS Nano. 2021 Sep 28;15(9):15166-15179. doi: 10.1021/acsnano.1c05618. Epub 2021 Sep 01.

The complete regression of residual tumors after photothermal therapy (PTT) depends on the activation and recognition of the immune system. However, the inevitable local inflammation after PTT in residual tumor recruits abundant abnormal immune cells, especially the tumor-associated macrophages...

Cite
Yue Y, Li F, Li Y, et al. Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy. ACS Nano. 2021;15(9):15166-15179doi: 10.1021/acsnano.1c05618.
Yue, Y., Li, F., Li, Y., Wang, Y., Guo, X., Cheng, Z., Li, N., Ma, X., Nie, G., & Zhao, X. (2021). Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy. ACS nano, 15(9), 15166-15179. https://doi.org/10.1021/acsnano.1c05618
Yue, Yale, et al. "Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy." ACS nano vol. 15,9 (2021): 15166-15179. doi: https://doi.org/10.1021/acsnano.1c05618
Yue Y, Li F, Li Y, Wang Y, Guo X, Cheng Z, Li N, Ma X, Nie G, Zhao X. Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy. ACS Nano. 2021 Sep 28;15(9):15166-15179. doi: 10.1021/acsnano.1c05618. Epub 2021 Sep 01. PMID: 34469109.
Copy Download .nbib Format: NLM
Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma.

Thoracic cancer

Diao FY.
PMID: 32686281
Thorac Cancer. 2020 Sep;11(9):2383-2384. doi: 10.1111/1759-7714.13549. Epub 2020 Jul 19.

No abstract available.

Cite
Diao FY. Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma. Thorac Cancer. 2020;11(9):2383-2384doi: 10.1111/1759-7714.13549.
Diao, F. Y. (2020). Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma. Thoracic cancer, 11(9), 2383-2384. https://doi.org/10.1111/1759-7714.13549
Diao, Fei-Yu. "Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma." Thoracic cancer vol. 11,9 (2020): 2383-2384. doi: https://doi.org/10.1111/1759-7714.13549
Diao FY. Novel mechanism of immune evasion mediated by tumor-associated macrophages in esophageal squamous cell carcinoma. Thorac Cancer. 2020 Sep;11(9):2383-2384. doi: 10.1111/1759-7714.13549. Epub 2020 Jul 19. PMID: 32686281; PMCID: PMC7471016.
Copy Download .nbib Format: NLM
Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded .

Nano letters

Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X, Zhou S.
PMID: 33998789
Nano Lett. 2021 May 26;21(10):4231-4240. doi: 10.1021/acs.nanolett.1c00209. Epub 2021 May 17.

The tumor immunosuppressive microenvironment greatly limits the efficacy of immunotherapy. Tumor-associated macrophages (TAMs) are the most abundant immunosuppressive cells in the tumor microenvironment, which can inhibit the tumor after converting it to an M1-like phenotype. In addition, immunogenic cell...

Cite
Wei B, Pan J, Yuan R, et al. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded . Nano Lett. 2021;21(10):4231-4240doi: 10.1021/acs.nanolett.1c00209.
Wei, B., Pan, J., Yuan, R., Shao, B., Wang, Y., Guo, X., & Zhou, S. (2021). Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded . Nano letters, 21(10), 4231-4240. https://doi.org/10.1021/acs.nanolett.1c00209
Wei, Baicheng, et al. "Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded ." Nano letters vol. 21,10 (2021): 4231-4240. doi: https://doi.org/10.1021/acs.nanolett.1c00209
Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X, Zhou S. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded . Nano Lett. 2021 May 26;21(10):4231-4240. doi: 10.1021/acs.nanolett.1c00209. Epub 2021 May 17. PMID: 33998789.
Copy Download .nbib Format: NLM
[Ⅴ. Novel Immunotherapies Targeting Tumor-Associated Macrophages].

Gan to kagaku ryoho. Cancer & chemotherapy

Takahashi H.
PMID: 34267027
Gan To Kagaku Ryoho. 2021 Jul;48(7):907-909.

No abstract available.

Cite
Takahashi H. [Ⅴ. Novel Immunotherapies Targeting Tumor-Associated Macrophages]. Gan To Kagaku Ryoho. 2021;48(7):907-909
Takahashi, H. (2021). [Ⅴ. Novel Immunotherapies Targeting Tumor-Associated Macrophages]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(7), 907-909.
Takahashi, Hideyuki. "[Ⅴ. Novel Immunotherapies Targeting Tumor-Associated Macrophages]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,7 (2021): 907-909.
Takahashi H. [Ⅴ. Novel Immunotherapies Targeting Tumor-Associated Macrophages]. Gan To Kagaku Ryoho. 2021 Jul;48(7):907-909. Japanese. PMID: 34267027.
Copy Download .nbib Format: NLM
Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines.

Advanced healthcare materials

Cheng Y, Song S, Wu P, Lyu B, Qin M, Sun Y, Sun A, Mu L, Xu F, Zhang L, Wang J, Zhang Q.
PMID: 34292673
Adv Healthc Mater. 2021 Sep;10(18):e2100590. doi: 10.1002/adhm.202100590. Epub 2021 Jul 22.

As an important part of tumor microenvironment, tumor associated macrophages (TAMs) play a vital role in the occurrence, development, invasion, and metastasis of many malignant tumors and can significantly promote the formation of tumor blood vessels and lymphatic vessels,...

Cite
Cheng Y, Song S, Wu P, et al. Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines. Adv Healthc Mater. 2021;10(18):e2100590doi: 10.1002/adhm.202100590.
Cheng, Y., Song, S., Wu, P., Lyu, B., Qin, M., Sun, Y., Sun, A., Mu, L., Xu, F., Zhang, L., Wang, J., & Zhang, Q. (2021). Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines. Advanced healthcare materials, 10(18), e2100590. https://doi.org/10.1002/adhm.202100590
Cheng, Yuxi, et al. "Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines." Advanced healthcare materials vol. 10,18 (2021): e2100590. doi: https://doi.org/10.1002/adhm.202100590
Cheng Y, Song S, Wu P, Lyu B, Qin M, Sun Y, Sun A, Mu L, Xu F, Zhang L, Wang J, Zhang Q. Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines. Adv Healthc Mater. 2021 Sep;10(18):e2100590. doi: 10.1002/adhm.202100590. Epub 2021 Jul 22. PMID: 34292673.
Copy Download .nbib Format: NLM
M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.

Annals of medicine

JiaWei Z, ChunXia D, CunDong L, Yang L, JianKun Y, HaiFeng D, Cheng Y, ZhiPeng H, HongYi W, DeYing L, ZhiJian L, Xiao X, QiZhao Z, KangYi X, WenBing G, Ming X, JunHao Z, JiMing B, ShanChao Z, MingKun C.
PMID: 34032524
Ann Med. 2021 Dec;53(1):730-740. doi: 10.1080/07853890.2021.1924396.

BACKGROUND: Prostate cancer (PCa) is poor response to the immunotherapy for its high heterogeneity of immune microenvironment. In this study, we aim to introduce a new immune subtype for PCa involving M2 tumour associated macrophages METHODS: Three hundred and...

Cite
JiaWei Z, ChunXia D, CunDong L, et al. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer. Ann Med. 2021;53(1):730-740doi: 10.1080/07853890.2021.1924396.
JiaWei, Z., ChunXia, D., CunDong, L., Yang, L., JianKun, Y., HaiFeng, D., Cheng, Y., ZhiPeng, H., HongYi, W., DeYing, L., ZhiJian, L., Xiao, X., QiZhao, Z., KangYi, X., WenBing, G., Ming, X., JunHao, Z., JiMing, B., ShanChao, Z., & MingKun, C. (2021). M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer. Annals of medicine, 53(1), 730-740. https://doi.org/10.1080/07853890.2021.1924396
JiaWei, Zhou, et al. "M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer." Annals of medicine vol. 53,1 (2021): 730-740. doi: https://doi.org/10.1080/07853890.2021.1924396
JiaWei Z, ChunXia D, CunDong L, Yang L, JianKun Y, HaiFeng D, Cheng Y, ZhiPeng H, HongYi W, DeYing L, ZhiJian L, Xiao X, QiZhao Z, KangYi X, WenBing G, Ming X, JunHao Z, JiMing B, ShanChao Z, MingKun C. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer. Ann Med. 2021 Dec;53(1):730-740. doi: 10.1080/07853890.2021.1924396. PMID: 34032524; PMCID: PMC8158194.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries